ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

FDA says official spoke on own behalf in admonition to The Cancer Letter. Association of Health Care Journalists asks FDA official to rescind her rebuke.

March 18, 2005

NCI advisory Group, Other Cancer Meetings

March 29, 1985

Study: Gene Assay Can Provide Valid Prognostic Information

January 31, 2014

Chabner Calls For Audit Of I-ELCAP Data, Full Financial Disclosure.

May 2, 2008

Competing Strategies For Breast Cancer? Brinker Tries to Ensure acceptance Of Report, Visco Urges Broad Effort

October 8, 1993

Senate Kills Plan to Increase Tax On Higher Tar, Nicotine Cigarettes

August 13, 1976